Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

European shares rise on vaccine hopes; Brexit talks eyed

Published 12/01/2020, 03:14 AM
Updated 12/01/2020, 05:05 AM
© Reuters. The German share price index DAX graph at the stock exchange in Frankfurt

By Susan Mathew

(Reuters) - European shares on Tuesday made a positive start to the month following record-breaking gains in November, with optimism around a coronavirus vaccine strengthening the case for an economic recovery.

After a day's dip, when investors took some profits, the pan-European STOXX 600 index was back in the black, up 0.8%. The index ended November with gains of nearly 14%.

However, Stanhope Capital's Chief Investment Officer Jonathan Bell warned it may be difficult to keep up November's rally, given how high valuations are.

"Going to December there'll be little bit of a pause despite all the good news surrounding vaccines," Bell said, also highlighting the pressure on GDP from coronavirus-induced lockdowns put in place last month.

Data on Tuesday showed lockdowns in France and Italy slowed manufacturing activity in November.

But keeping hopes of economic recovery alive, a business survey echoed official numbers from a day earlier which showed robust growth in China's factory activity.

Investors, however, may have already started to price in consistently good data from China, Bell said.

On the Brexit front, the European Union will launch contingency measures on Wednesday or Thursday, if it is unable to reach an agreement by then with Britain, a senior EU diplomat said. UK's Brexit supremo, Michael Gove said on Tuesday talks are still stuck on fishing, governance rules and dispute resolution.

After marking its best month in over three decades, London's blue-chip index rallied 1.5% to lead gains among regional peers, attempting to make up last session's losses.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Among other events this month, some European nations are set to lift curbs put in place to control the spread of the novel coronavirus, Britain is due to return to a regional approach to restrictions from Dec. 2, while the European Central Bank's meeting will be eyed for policy easing.

Ipsen SA jumped 2% after the French healthcare company said it expected to generate some cumulative 3 billion euros ($3.59 billion) to power its pipeline expansion by 2024, excluding asset sales.

Italian lender Unicredit (MI:CRDI) SpA fell 5.7% after it said Chief Executive Officer Jean Pierre Mustier will step down in April next year over disagreements with the board.

Latest comments

European shares rise on hope that economy will be at level of 2019 in the middle of 2021
USD coming... who cares about the COVID, they will leave at time of EURUSD 1.25
Again the hopes???what about the results of the lockdowns??!!
doesnt matter, dax 20k
market is always forward looking. lockdowns will end.
....
when Novawax releases results?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.